These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17886338)

  • 61. Cell-mediated cytotoxicity against human tumors: lessons learned and future prospects.
    Herberman RB; Oldham RK
    J Biol Response Mod; 1983; 2(2):111-20. PubMed ID: 6196451
    [No Abstract]   [Full Text] [Related]  

  • 62. [The defense mechanism and its weakening: the defense mechanism prior to immunity].
    Nomoto K
    Nihon Rinsho; 1986 Sep; 44(9):1954-9. PubMed ID: 2432291
    [No Abstract]   [Full Text] [Related]  

  • 63. Dysregulated anti-viral innate immune cascade during aging.
    Stotesbury C; Sigal LJ
    Aging (Albany NY); 2021 Jan; 13(2):1566-1567. PubMed ID: 33510045
    [No Abstract]   [Full Text] [Related]  

  • 64. [Biochemical and cellular natural resistance factors in oral neoplasms].
    Viti M; Barucchi AM; Iemmola G; Mazzoni L
    Stomatol Mediterr; 1987; 7(4):429-40. PubMed ID: 2471280
    [No Abstract]   [Full Text] [Related]  

  • 65. Finding a role for Th17 cells in hepatitis C pathogenesis.
    Bowen DG
    J Gastroenterol Hepatol; 2012 Feb; 27(2):188-91. PubMed ID: 22260280
    [No Abstract]   [Full Text] [Related]  

  • 66. Flow cytometry makes all the difference.
    Pembroke T; Gallimore A; Godkin A
    J Hepatol; 2013 Oct; 59(4):909-10. PubMed ID: 23792877
    [No Abstract]   [Full Text] [Related]  

  • 67. Reply to: "Flow cytometry makes all the difference".
    Oliviero B; Mele D; Varchetta S; Mondelli MU
    J Hepatol; 2013 Oct; 59(4):910-1. PubMed ID: 23796476
    [No Abstract]   [Full Text] [Related]  

  • 68. Another earth: innate lymphoid cells and intestinal inflammation.
    Lin L; Braun J
    Gastroenterology; 2011 Nov; 141(5):1542-4. PubMed ID: 21959073
    [No Abstract]   [Full Text] [Related]  

  • 69. The role of interferons in preschool wheeze.
    Makrinioti H; Custovic A; Hasegawa K; Camargo CA; Jartti T
    Lancet Respir Med; 2021 Jan; 9(1):9-11. PubMed ID: 33412119
    [No Abstract]   [Full Text] [Related]  

  • 70. Immunity against hepatitis C virus infection.
    Dore GJ; Freeman AJ; Kaldor JM
    Lancet; 2002 Sep; 360(9338):1019-20; author reply 1020-1. PubMed ID: 12383685
    [No Abstract]   [Full Text] [Related]  

  • 71. Impact of IFN-Free and IFN-Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan-DC, and Activated T Lymphocyte Dynamics during HCV Infection.
    Vita S; Zuccalà P; Savinelli S; Mascia C; Rossi R; Schiavone F; Marocco R; Tieghi T; Iannetta M; Nijhawan P; Zingaropoli MA; d'Ettore G; Vullo V; Mastroianni CM; Lichtner M
    J Immunol Res; 2020; 2020():2781350. PubMed ID: 32258171
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Daclatasvir and Sofosbuvir Therapy Enhance Monocyte Phenotypic Changes in Naive Chronic Hepatitis C Patients: A Prospective Cohort Study.
    Fayed HM; Ghweil AA; AbdelMeguid MM
    Interdiscip Perspect Infect Dis; 2019; 2019():9469567. PubMed ID: 30941170
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Interaction and Mutual Activation of Different Innate Immune Cells Is Necessary to Kill and Clear Hepatitis C Virus-Infected Cells.
    Klöss V; Grünvogel O; Wabnitz G; Eigenbrod T; Ehrhardt S; Lasitschka F; Lohmann V; Dalpke AH
    Front Immunol; 2017; 8():1238. PubMed ID: 29085359
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dynamic Changes of the Frequency of Classic and Inflammatory Monocytes Subsets and Natural Killer Cells in Chronic Hepatitis C Patients Treated by Direct-Acting Antiviral Agents.
    Ning G; Li YT; Chen YM; Zhang Y; Zeng YF; Lin CS
    Can J Gastroenterol Hepatol; 2017; 2017():3612403. PubMed ID: 28567369
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genotype-Associated Differential NKG2D Expression on CD56+CD3+ Lymphocytes Predicts Response to Pegylated-Interferon/Ribavirin Therapy in Chronic Hepatitis C.
    Chu PS; Ebinuma H; Nakamoto N; Sugiyama K; Usui S; Wakayama Y; Taniki N; Yamaguchi A; Shiba S; Yamagishi Y; Wakita T; Hibi T; Saito H; Kanai T
    PLoS One; 2015; 10(5):e0125664. PubMed ID: 25965701
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Innate immune cell networking in hepatitis C virus infection.
    Saha B; Szabo G
    J Leukoc Biol; 2014 Nov; 96(5):757-66. PubMed ID: 25001860
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Viral (hepatitis C virus, hepatitis B virus, HIV) persistence and immune homeostasis.
    Zhou Y; Zhang Y; Moorman JP; Yao ZQ; Jia ZS
    Immunology; 2014 Nov; 143(3):319-30. PubMed ID: 24965611
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Regulation of host innate immunity by hepatitis C virus: crosstalk between hepatocyte and NK/DC.
    Park SJ; Hahn YS
    Rev Infect; 2010 Jul; 1(3):151-157. PubMed ID: 24688607
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dendritic cell co-stimulatory and co-inhibitory markers in chronic HCV: an Egyptian study.
    Fouad H; Raziky MS; Aziz RA; Sabry D; Aziz GM; Ewais M; Sayed AR
    World J Gastroenterol; 2013 Nov; 19(43):7711-8. PubMed ID: 24282359
    [TBL] [Abstract][Full Text] [Related]  

  • 80. TGF-β signal shifting between tumor suppression and fibro-carcinogenesis in human chronic liver diseases.
    Matsuzaki K; Seki T; Okazaki K
    J Gastroenterol; 2014 Jun; 49(6):971-81. PubMed ID: 24263677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.